2026 NPPES data Foot & Ankle Surgery Podiatrist NPI 1386050060 DPM
Verify on CMS →

STEVEN O'BRYANT, DPM

Foot & Ankle Surgery Podiatrist in CHANDLER, Arizona. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
214
Medicare Part D claims · 93 beneficiaries · Foot & Ankle Surgery Podiatrist avg: 309
Generic prescribing
91%
generic claims · 9% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.0K
8 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

STEVEN O'BRYANT, DPM filed 214 Medicare Part D claims in 2023 as a Foot & Ankle Surgery Podiatrist in CHANDLER, Arizona, prescribing 91% generic.

214
Part D claims, 2023
91%
generic prescribing
$1.0K
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

STEVEN O'BRYANT, DPM's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

214 49th percentile higher than 49% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about STEVEN O'BRYANT, DPM?

Quality data not reported

NPI registry status

Active

Issued 07/02/2014

NPI 1386050060

Primary specialty

Foot & Ankle Surgery Podiatrist

Mid-sized

8,920 US NPIs in this specialty

Medicare Part D claims

214 31% vs specialty avg

2023 prescription claims

Specialty avg: 309

Specialty distribution in Arizona

How Foot & Ankle Surgery Podiatrist compares to other specialties among Arizona providers

Arizona providers

Foot & Ankle Surgery Podiatrist share within Arizona

1. Foot & Ankle Surgery Podiatrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Foot & Ankle Surgery Podiatrist share within Arizona

Specialty board-certification context

Estimated specialty board-certified rate — Foot & Ankle Surgery Podiatrist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Foot & Ankle Surgery Podiatrist ABMS/AOA estimate

Est. board-certified rate (Foot & Ankle Surgery Podiatrist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Foot & Ankle Surgery Podiatrist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

STEVEN O'BRYANT, DPM appears in the CMS NPPES registry as a Foot & Ankle Surgery Podiatrist provider holding DPM credentials at 955 N MCQUEEN RD STE 1, CHANDLER, AZ, 85225, with a listed phone of (480) 744-6234. NPI 1386050060 was issued on 07/02/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what O'BRYANT most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 214 prescription claims written by this provider, covering 93 Medicare beneficiaries and totaling roughly $6K in drug spend, split 9% brand-name and 91% generic by claim count, with an opioid prescribing rate of 7.9%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Foot & Ankle Surgery Podiatrist is a mid-sized specialty nationwide, with 8,920 enrolled providers across 53 states and an average of 309 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

955 N MCQUEEN RD STE 1
CHANDLER, AZ 85225

Provider Details

NPI 1386050060
Specialty Foot & Ankle Surgery Podiatrist
Credentials DPM
Gender Male
NPI Issued 07/02/2014

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for STEVEN O'BRYANT, DPM. Source: openpaymentsdata.cms.gov.

Total received

$1.0K

Largest payer

MedShape, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

STEVEN O'BRYANT, DPM — brand share 9.0%
Specialty average (est.)

9% brand-name claims vs 91% generic, on 214 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

214
Total Claims
$6K
Total Drug Cost
93
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
266
Total Day Supply
5,845
Brand vs Generic
9% brand / 91% generic
Brand Drug Cost
$3K
Generic Drug Cost
$3K
Opioid Claims
17 (7.9% rate)
Antibiotic Claims
66

Patient Demographics

Average Patient Age
69.0 years
Avg HCC Risk Score
2.20
Gender Split
47% female / 53% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What STEVEN O'BRYANT, DPM prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
37
Terbinafine Hcl
22
Gabapentin
19
Diclofenac Sodium
17
Clotrimazole-Betamethasone
Clotrimazole/Betamethasone Dip
13
Oxycodone Hcl
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Foot & Ankle Surgery Podiatrist Overview

How STEVEN O'BRYANT, DPM fits within the Foot & Ankle Surgery Podiatrist landscape nationally.

8,920
Foot & Ankle Surgery Podiatrist Providers in US
53
States with Foot & Ankle Surgery Podiatrist
309
Avg Claims per Provider

STEVEN O'BRYANT, DPM's 214 claims are below the specialty average of 309.

Nearby Foot & Ankle Surgery Podiatrist Providers in Arizona

Other clinicians with the same primary specialty enrolled in Arizona, drawn from the same CMS NPPES roster as O'BRYANT.

Compare Foot & Ankle Surgery Podiatrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is STEVEN O'BRYANT, DPM's specialty?
STEVEN O'BRYANT, DPM specializes in Foot & Ankle Surgery Podiatrist and practices in CHANDLER, Arizona. Credentials: DPM.
How much does STEVEN O'BRYANT, DPM prescribe under Medicare Part D?
In 2023, STEVEN O'BRYANT, DPM wrote 214 Medicare Part D claims totaling $6K in drug costs for 93 beneficiaries.
Where is STEVEN O'BRYANT, DPM located?
STEVEN O'BRYANT, DPM is located at 955 N MCQUEEN RD STE 1, CHANDLER, AZ, 85225. Phone: (480) 744-6234.
What is STEVEN O'BRYANT, DPM's NPI number?
STEVEN O'BRYANT, DPM's National Provider Identifier (NPI) is 1386050060, issued on 07/02/2014.
Does STEVEN O'BRYANT, DPM prescribe more brand-name or generic drugs?
STEVEN O'BRYANT, DPM's prescribing is 9% brand-name and 91% generic drugs by claim count, with $3K in brand drug costs.
Does STEVEN O'BRYANT, DPM prescribe opioids?
Yes, STEVEN O'BRYANT, DPM had 17 opioid claims in 2023 with an opioid prescribing rate of 7.9%.
How many Foot & Ankle Surgery Podiatrist providers are there in the US?
There are 8,920 Foot & Ankle Surgery Podiatrist providers across 53 states in the US. The average Foot & Ankle Surgery Podiatrist provider writes 309 Medicare Part D claims per year.
What drugs does STEVEN O'BRYANT, DPM prescribe most often?
Based on 2023 Medicare Part D data, STEVEN O'BRYANT, DPM's most frequently prescribed drugs include Amoxicillin-Clavulanate Potass, Terbinafine Hcl, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does STEVEN O'BRYANT, DPM accept Medicare?
STEVEN O'BRYANT, DPM appears in CMS Medicare data with 214 Part D claims and 93 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify STEVEN O'BRYANT, DPM's credentials?
STEVEN O'BRYANT, DPM's NPI is 1386050060 with credentials DPM. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology